Description
Book SynopsisThis book is designed to be a ready reckoner on commonly used medications for the treatment of diabetes mellitus.
Divided into 17 sections, topics include incretin-based therapies, insulin, chloroquine, metformin, colesevelam, drugs targeting renal excretion of glucose, management of dyslipidaemia, and more.
The book concludes with discussion on associated comorbidities such as hypertension and diabetes in the elderly.
Drug classes featured are all approved in-line with FDA (United States Food and Drug Administration) guidelines.
Authored by recognised, US-based experts in the field, the comprehensive text is further enhanced by clinical photographs, diagrams and tables.
Key points
- Comprehensive guide to pharmaceutical treatments for diabetes mellitus
- Features approved drugs in-line with FDA (United States Food and Drug Administration) guidelines
- Includes discussion on commonly associated comorbidities such as hypertension, and diabetes in the elderly
- Internationally recognised, US-based author team
Table of Contents
- Incretin Based Therapies: DPP-IV Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
- Insulin Secretagogues: Non-sulfonylureas Glinides (Repaglinide, Nateglinide)
- Incretin Based Therapies: DPP IV Inhibitors
- Management of Dyslipidaemia in Diabetes
- Chloroquine in the Treatment of Diabetes Mellitus
- Colesevelam in Type 2 Diabetes Mellitus
- GLP1 Agonists
- Dopamine-D2 Receptor Agonists: Bromocriptine in the Management of Type 2 Diabetes
- Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
- Insulin: Pumps and CGMS
- Insulin Sensitizers
- Management of Type 2 Diabetes: A Patient-centered Approach
- Metformin
- Drugs Targeting Renal Excretion of Glucose: SGLT2 Inhibitors
- Second Generation Sulfonylureas: History, Pharmacology and Applied Aspects
- Diabetes in the Elderly
- Management of Hypertension in Diabetes
